This FDR threshold included five pathways listed in Supplementary Figure 1A and named TGF-β receptor signaling in skeletal disease, transcriptional regulation of white adipocyte (TRWA), TGF-β receptor signaling, TNF-α, and GPCRS, Class A Rhodopsin-Like (GCRL). The gene discussed is ENSG00000276393; the disease is bone disorder.